Andrew Bowser

Texas Oncology

911 Foster Lane




Prostate Ca patients urged to consult a medical oncologist

November 01, 2004

New York--Men with prostate cancer are being urged to seek the advice of a medical oncologist in a new educational campaign launched by the Prostate Cancer Foundation.

Adjuvant IL-2 offers survival benefit in metastatic RCC

September 01, 2002

Orlando, FL-In patients with metastatic renal cell carcinoma, adjuvant interleukin-2 (IL-2) after cytoreductive nephrectomy appears to offer a superior survival benefit over nephrectomy followed by interferon alpha-2b, according to a report presented here at the American Society of Clinical Oncology annual meeting.